US Patent 11007144 Pharmaceutical formulation
All edits
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+502 characters)
Article
Patent abstract
The present invention relates to a film comprising an alginate salt of a monovalent cation or a mixture of alginate salts containing at least one alginate salt of a monovalent cation, and a triptan or a pharmaceutically acceptable salt thereof. The present invention further relates to methods for manufacturing such a film, and the use of such a film in the treatment of disease in a human patient, in particular migraine with or without aura, cluster headache, or trigeminal neuralgia.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Fredrik Hübinette0
Leif Ingemarsson0
Scott Boyer0
Susan Suchdev0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110071440
Date of Patent
May 18, 2021
0Patent Application Number
163498400
Date Filed
November 14, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11007144 Pharmaceutical formulation
Infobox
Is a
Patent jurisdiction
Patent number
11007144
Date of patent
May 18, 2021
Patent application number
16349840
Date Filed
November 14, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11007144 Pharmaceutical formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
